PT Shield On Service Tbk (IDX:SOSS)
Indonesia · Delayed Price · Currency is IDR 414.00
-4.00 (-0.96%)
Aug 1, 2025, 3:14 PM WIB
SpringWorks Therapeutics Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 1,876,078 | 1,870,249 | 1,780,353 | 1,529,120 | 1,389,332 | 1,368,036 | Upgrade | |
Revenue Growth (YoY) | 2.13% | 5.05% | 16.43% | 10.06% | 1.56% | 1.48% | Upgrade |
Cost of Revenue | 1,721,526 | 1,713,217 | 1,607,075 | 1,365,515 | 1,240,606 | 1,238,804 | Upgrade |
Gross Profit | 154,552 | 157,032 | 173,278 | 163,605 | 148,726 | 129,231 | Upgrade |
Selling, General & Admin | 135,349 | 134,382 | 130,418 | 121,811 | 102,713 | 104,502 | Upgrade |
Other Operating Expenses | 254.63 | 234.51 | 318.9 | 1,381 | 43.09 | 1,439 | Upgrade |
Operating Expenses | 135,604 | 134,616 | 130,737 | 123,192 | 102,756 | 105,941 | Upgrade |
Operating Income | 18,948 | 22,416 | 42,541 | 40,413 | 45,970 | 23,290 | Upgrade |
Interest Expense | -10,066 | -10,826 | -11,842 | -12,975 | -11,283 | -13,000 | Upgrade |
Interest & Investment Income | 745.21 | 968.05 | 778.06 | 569 | 677.38 | 817.4 | Upgrade |
Other Non Operating Income (Expenses) | 15,221 | 15,712 | 16,969 | 12,037 | 9,615 | 13,910 | Upgrade |
EBT Excluding Unusual Items | 24,849 | 28,270 | 48,446 | 40,044 | 44,980 | 25,018 | Upgrade |
Gain (Loss) on Sale of Assets | 1,373 | 1,646 | 751.15 | 283.51 | 972.12 | 451.43 | Upgrade |
Pretax Income | 26,221 | 29,916 | 49,198 | 40,328 | 45,952 | 25,469 | Upgrade |
Income Tax Expense | 16,388 | 17,661 | 14,646 | 11,485 | 13,320 | 8,980 | Upgrade |
Earnings From Continuing Operations | 9,833 | 12,255 | 34,552 | 28,842 | 32,632 | 16,489 | Upgrade |
Minority Interest in Earnings | -4,610 | -6,568 | -6,933 | -5,012 | -4,363 | 150.23 | Upgrade |
Net Income | 5,223 | 5,687 | 27,618 | 23,830 | 28,270 | 16,640 | Upgrade |
Net Income to Common | 5,223 | 5,687 | 27,618 | 23,830 | 28,270 | 16,640 | Upgrade |
Net Income Growth | -75.92% | -79.41% | 15.90% | -15.71% | 69.89% | -38.60% | Upgrade |
Shares Outstanding (Basic) | 799 | 799 | 595 | 793 | 769 | 656 | Upgrade |
Shares Outstanding (Diluted) | 799 | 799 | 595 | 811 | 786 | 677 | Upgrade |
Shares Change (YoY) | - | 34.35% | -26.59% | 3.16% | 16.02% | 3.26% | Upgrade |
EPS (Basic) | 6.53 | 7.11 | 46.43 | 30.06 | 36.75 | 25.35 | Upgrade |
EPS (Diluted) | 6.53 | 7.11 | 46.43 | 29.40 | 35.98 | 24.57 | Upgrade |
EPS Growth | -75.92% | -84.68% | 57.93% | -18.29% | 46.44% | -40.54% | Upgrade |
Free Cash Flow | -33,232 | 18,315 | -19,195 | -21,940 | 19,055 | 16,737 | Upgrade |
Free Cash Flow Per Share | -41.57 | 22.91 | -32.26 | -27.07 | 24.25 | 24.71 | Upgrade |
Dividend Per Share | 2.000 | 2.000 | 10.000 | - | - | - | Upgrade |
Dividend Growth | -80.00% | -80.00% | - | - | - | - | Upgrade |
Gross Margin | 8.24% | 8.40% | 9.73% | 10.70% | 10.71% | 9.45% | Upgrade |
Operating Margin | 1.01% | 1.20% | 2.39% | 2.64% | 3.31% | 1.70% | Upgrade |
Profit Margin | 0.28% | 0.30% | 1.55% | 1.56% | 2.04% | 1.22% | Upgrade |
Free Cash Flow Margin | -1.77% | 0.98% | -1.08% | -1.44% | 1.37% | 1.22% | Upgrade |
EBITDA | 26,255 | 29,114 | 48,621 | 44,769 | 49,878 | 27,707 | Upgrade |
EBITDA Margin | 1.40% | 1.56% | 2.73% | 2.93% | 3.59% | 2.02% | Upgrade |
D&A For EBITDA | 7,307 | 6,698 | 6,080 | 4,356 | 3,908 | 4,417 | Upgrade |
EBIT | 18,948 | 22,416 | 42,541 | 40,413 | 45,970 | 23,290 | Upgrade |
EBIT Margin | 1.01% | 1.20% | 2.39% | 2.64% | 3.31% | 1.70% | Upgrade |
Effective Tax Rate | 62.50% | 59.04% | 29.77% | 28.48% | 28.99% | 35.26% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.